H. Sato et al., THE EFFECT OF 1,24(R)(OH)(2)D-3 CREAM AND OINTMENT ON EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN MICE, Dermatology, 192(3), 1996, pp. 233-238
Background: The 1,24(R)(OH)(2)D-3 (tacalcitol) ointment (2 mu g/g) is
available commercially as an antipsoriatic drug in Japan, but the crea
m preparation of tacalcitol is still under development. Objective: Thi
s study was conducted to compare the ability of tacalcitol cream and o
intment to inhibit epidermal proliferation and induce epidermal differ
entiation. Methods: We measured the ornithine decarboxylase activity a
nd type I transglutaminase activity as indices of proliferation and di
fferentiation, respectively, in hairless mice. Results: These effects
were statistically equal to those of the ointment preparation at the s
ame dose, 2 mu g/g, without inducing hypercalcemia. Conclusions: These
findings suggest that topical application of 1,24(OH)(2)D-3 cream (2
mu g/g) might have the same potency as the ointment formulation in the
treatment of psoriasis.